For Immediate Release

February 2, 2007

Sumitomo Chemical Reports
Consolidated Financial Results
For the Nine Months Ended December 31, 2006
Sumitomo Chemical Company, Limited today announced that its consolidated net sales for the ninemonths ended December 31, 2006 totaled ¥1,296.2 billion ($10,882 million), an increase of 18.1% over thesame period last year. Net income increased by 2.3% to ¥72.9 billion ($612 million).
Sales in the Basic Chemicals segment increased by ¥50.1 billion over the same period last year to ¥228.2billion. The increase was due to a substantial increase in sales of aluminum because of a rise in themarket price compared with last year as well as increased sales of caprolactam, the raw material forsynthetic textile fibers, and methyl methacrylate (MMA) because of production capacity expansions.
The Petrochemicals & Plastics segment saw a sales rise by ¥46.3 billion over the same period last year to¥397.8 billion. Sales of styrene monomer and other petrochemical products increased on the back offavorable market conditions that supported price increases taken in response to the rising prices offeedstocks such as naphtha. Firm sales of synthetic resins also contributed to the segment’s improved
year-on-year performance.
Sales in the Fine Chemicals segment increased by ¥11.6 billion year on year to ¥69.0 billion. The increases
were due to favorable sales of adhesives raw materials driven by firm demand as well as increased salesof pharmaceutical chemicals thanks to an increase in shipments of pharmaceutical intermediates.
Sales in the IT-related Chemicals segment increased by ¥39.0 billion over the same period last year to¥198.2 billion as a result of capacity expansions in Korea and Taiwan for polarizing film, a primarymaterial for liquid crystal displays.
Sales in the Agricultural Chemicals segment increased by ¥9.9 billion over the same period last year to¥138.2 billion. Feed additives saw an increase in sales owing to increases in selling prices reflecting asharp rise in the price of raw materials, and active marketing drives. Production capacity expansion
contributed to an increase in OLYSET®NET shipments. Sales of agrochemicals declined because of weak
demand in the Japanese market, while overseas sales of herbicides remained firm thanks to solidshipments.
Sales in the Pharmaceuticals segment increased by ¥8.9 billion over the previous year to ¥175.5 billion.
The Company’s pharmaceutical subsidiary, Sumitomo Pharmaceuticals Co., Ltd., merged with Dainippon
Pharmaceutical Co., Ltd. in October 2005 to form Dainippon Sumitomo Pharma Co., Ltd. (DSP), increasing
the scale of the segment’s operations, and sales of DSP’s four main products, Amlodin (therapeutic agent
for hypertension and angina), Gasmotin (gastroprokinetic), Meropen (carbapenem antibiotic), andProrenal (vasodilator) remained firm.
Total operating income increased by ¥17.0 billion to ¥105.4 billion. Operating income in the Basic
Chemicals segment increased by ¥2.2 billion year on year to ¥9.5 billion, and in the Petrochemicals &Plastics segment it increased by ¥4.7 billion year on year to ¥17.5 billion. Operating income in the Fine
Chemicals segment increased by ¥2.7 billion to ¥10.0 billion, while in the IT-related Chemicals segment, it
declined year on year by ¥6.2 billion to ¥8.6 billion because of decreasing selling prices. In theAgricultural Chemicals segment, operating income increased by ¥3.8 billion to ¥13.2 billion, and in thePharmaceuticals segment it increased by ¥8.3 billion to ¥42.7 billion.
Net income increased by ¥1.6 billion to ¥72.9 billion due mainly to an extraordinary gain on sale ofinvestment securities, including shares of GlaxoSmithKline K.K., in addition to the growth of operating
income.
(Note) *U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥119.11= $1 prevailing on December 31, 2006.
(Cautionary Statement)
Statements made in this release with respect to the Company’s current plans, estimates, strategies and beliefs that are not historicalfacts are forward-looking statements about the future performance of Sumitomo Chemical. These statements are based on
management’s assumptions and beliefs in light of the information currently available to it, and involve risks and uncertainties. The
important factors that could cause actual results to differ materially from those discussed in the forward-looking statements include, but
are not limited to, general economic conditions in Sumitomo Chemical’s markets; demand for, and competitive pricing pressure on,
Sumitomo Chemical’s products in the marketplace; Sumitomo Chemical’s ability to continue to win acceptance for its products in thesehighly competitive markets; and movements of currency exchange rates.

Summary of Consolidated Results(1) Results of operations:
9 Months ended
December 31, 2006
Net Sales
Operating Income
Income Before Income Taxes
and Minority Interests
Net Income

Net income per 1,000 shares（\\ Million ）1,296,206
105,404（$140,567
72,9149 Months ended
December 31, 2005

US$ 1,000 ）
10,882,428
884,930*（\1,180,144612,157\ Million ）1,097,844
88,411
127,176
71,301）*（\）
Yen
44,142（\\ Million ）2,262,374
1,001,634（$US$ 1,000 ）
18,993,989
8,409,319*（\\ Million ）2,178,377
719,760（\）
Yen
464,830（$）
US$3,903*（\Yen）
435,510（$US$371（\Yen）
43,143(2) Financial Position:
As of December 31, 2006
Total Assets
Total Net Assets

Book Value per 1,000 shares

As of March 31, 2006

(3) Results of Operations by Business Segment:
9 Months ended
December 31, 2006
（Net Sales
Basic ChemicalsPetrochemicals & Plastics
Fine Chemicals
IT-related Chemicals
Agricultural Chemicals
Pharmaceuticals
Others\\Operating Income
Basic Chemicals
Petrochemicals & Plastics
Fine Chemicals
IT-related Chemicals
Agricultural Chemicals
Pharmaceuticals
OthersElimination\\9 Months ended
December 31, 2005（

*US$ 1,000 ）（228,195
397,768
68,962
198,213138,246
175,475
89,347
1,296,206$

1,915,834
3,339,501
578,977
1,664,117
1,160,658
1,473,218
750,122
10,882,428\9,501
17,483
9,984
8,590
13,162
42,696
4,912(924)
105,404$79,767
146,780
83,822
72,118110,503358,459
41,239(7,758)884,930\\ Million）$$\\(Note)*U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥119.11= $1 prevailing on December 31, 2006.

\ Million
178,126
351,470
57,313
159,185
128,317
166,560
56,873
1,097,844
7,254
12,751
7,253
14,826
9,396
34,3592,647(75)
88,411）